Jikun Feng
Overview
Explore the profile of Jikun Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiong Z, Yang L, Zhang C, Huang W, Zhong W, Yi J, et al.
Autophagy
. 2024 Aug;
21(1):80-101.
PMID: 39147386
During tumor expansion, breast cancer (BC) cells often experience reactive oxygen species accumulation and mitochondrial damage because of glucose shortage. However, the mechanism by which BC cells deal with the...
2.
Huang W, Xiong Z, Zhong W, Zhang C, Feng J, Wang X
Gland Surg
. 2023 Dec;
12(11):1459-1474.
PMID: 38107499
Background: The systemic inflammation response index (SIRI) has been reported to associate with survival outcomes in breast cancer patients. However, the effects of baseline SIRI and SIRI change after neoadjuvant...
3.
Wu H, Feng J, Zhong W, Zouxu X, Xiong Z, Huang W, et al.
Front Immunol
. 2023 Mar;
14:1151800.
PMID: 36999020
Introduction: Compared to other types of breast cancer, triple-negative breast cancer (TNBC) does not effectively respond to hormone therapy and HER2 targeted therapy, showing a poor prognosis. There are currently...
4.
Wu H, Feng J, Wu J, Zhong W, Zouxu X, Huang W, et al.
J Cancer Res Clin Oncol
. 2022 Sep;
149(8):4367-4380.
PMID: 36109402
Background: Triple-negative breast cancer (TNBC) is resistant to targeted therapy with HER2 monoclonal antibodies and endocrine therapy, because it lacks the estrogen receptor (ER), progesterone receptor (PR), and human epidermal...
5.
Xiong Z, Huang W, Zhong W, Fu J, Feng J, Wang X, et al.
Front Mol Biosci
. 2022 Jul;
9:900005.
PMID: 35847977
The hypoxic tumor microenvironment was reported to be involved in different tumorigenesis mechanisms of breast cancer (BC). We aimed to establish a hypoxia-related gene signature to identify a new BC...
6.
Feng J, Yi J, Zouxu X, Li J, Xiong Z, Huang X, et al.
Cancer Med
. 2022 Apr;
11(15):2923-2933.
PMID: 35411609
Background: Host immunity plays an important role in tumor development and treatment. Tumor-infiltrating lymphocytes (TILs) have been proven to predict the efficacy of neoadjuvant therapy (NAT) in breast cancer (BC)...
7.
Feng J, Yao H, Chen L, Wang W
Natl Sci Rev
. 2022 Apr;
9(4):nwab174.
PMID: 35386921
Significant left-lateral movement along the Ailao Shan-Red River fault accommodated a substantial amount of the late Eocene to early Miocene India-Asia convergence. However, the activation of this critical strike-slip fault...
8.
Zhong W, Yi J, Wu H, Zou X, Feng J, Huang X, et al.
Future Oncol
. 2022 Mar;
18(14):1745-1756.
PMID: 35227076
The authors aimed to evaluate the prognostic and predictive value of androgen receptor (AR) expression in patients with luminal/human EGFR2 negative (HER2-) T1N0 breast cancer. The cohort in this retrospective...
9.
Ke L, Shen J, Feng J, Chen J, Shen S, Li S, et al.
Front Mol Biosci
. 2022 Feb;
8:800679.
PMID: 35118119
The features and significance of somatic mutation profiles in hepatocellular carcinoma (HCC) have not been completely elucidated to date. In this study, 39 tumor specimens from HCC patients were collected...
10.
Wu H, Huang X, Chen S, Li S, Feng J, Zouxu X, et al.
Transl Cancer Res
. 2022 Feb;
9(10):6369-6382.
PMID: 35117245
Background: An increasing amount of research over recent years on the anti-metastasis function of the non-metastatic () gene family has been challenged, with some studies identifying its involvement in the...